STOCK TITAN

[8-K] bioAffinity Technologies, Inc. Warrant Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Annaly Capital Management (NYSE: NLY) has filed a preliminary 424B5 prospectus supplement to issue an unspecified number of Series J Fixed-Rate Cumulative Redeemable Preferred shares with a $25 liquidation preference. The dividend coupon, expressed as “%,” has not yet been fixed. Cash dividends will accrue from the issue date and be paid quarterly, commencing 31 Dec 2025 (long first period), and will be cumulative.

Redemption & conversion: The shares are non-redeemable until 30 Sep 2030 except to preserve REIT status or following a Change of Control (CoC). Thereafter, Annaly may redeem at $25 plus unpaid dividends. Upon a CoC, holders can opt to convert into common stock at the lesser of (i) the liquidation preference plus accrued dividends divided by the “Common Stock Price,” or (ii) a share-cap formula. Shares not converted may be redeemed. The offering will be listed on the NYSE as “NLY.J” within 30 days of issuance, subject to approval.

Use of proceeds: Net proceeds will fund Annaly’s targeted investments—Agency MBS, TBA positions, mortgage-servicing rights and residential credit assets—and for general corporate purposes. No rating has been assigned. Transfer/ownership are capped at 9.8% to protect REIT status, and voting rights are limited to customary protective provisions.

Annaly Capital Management (NYSE: NLY) ha depositato un prospetto supplementare preliminare 424B5 per emettere un numero non specificato di azioni privilegiate cumulative rimborsabili a tasso fisso Serie J con una preferenza di liquidazione di $25. Il tasso del dividendo, espresso in “%,” non è ancora stato fissato. I dividendi in contanti matureranno dalla data di emissione e saranno pagati trimestralmente, a partire dal 31 dicembre 2025 (primo periodo lungo), e saranno cumulativi.

Rimborso e conversione: Le azioni sono non rimborsabili fino al 30 settembre 2030, salvo per preservare lo status REIT o in seguito a un cambio di controllo (CoC). Successivamente, Annaly potrà rimborsare a $25 più i dividendi non pagati. In caso di CoC, i detentori possono scegliere di convertire in azioni ordinarie al minore tra (i) la preferenza di liquidazione più i dividendi maturati diviso il “Prezzo delle Azioni Ordinarie,” o (ii) una formula basata sul numero di azioni. Le azioni non convertite potranno essere rimborsate. L’offerta sarà quotata alla NYSE come “NLY.J” entro 30 giorni dall’emissione, soggetta ad approvazione.

Utilizzo dei proventi: I proventi netti finanzieranno gli investimenti mirati di Annaly—MBS Agency, posizioni TBA, diritti di servicing ipotecario e attività di credito residenziale—e scopi aziendali generali. Non è stata assegnata alcuna valutazione. Il trasferimento e la proprietà sono limitati al 9,8% per proteggere lo status REIT, e i diritti di voto sono limitati alle consuete clausole protettive.

Annaly Capital Management (NYSE: NLY) ha presentado un suplemento preliminar 424B5 al prospecto para emitir un número no especificado de acciones preferentes acumulativas redimibles a tasa fija Serie J con una preferencia de liquidación de $25. El cupón del dividendo, expresado en “%,” aún no ha sido fijado. Los dividendos en efectivo se acumularán desde la fecha de emisión y se pagarán trimestralmente, comenzando el 31 de diciembre de 2025 (primer período largo), y serán acumulativos.

Redención y conversión: Las acciones son no redimibles hasta el 30 de septiembre de 2030, excepto para preservar el estatus REIT o tras un Cambio de Control (CoC). Posteriormente, Annaly podrá redimir a $25 más los dividendos no pagados. En caso de un CoC, los tenedores pueden optar por convertir en acciones ordinarias al menor entre (i) la preferencia de liquidación más los dividendos acumulados divididos por el “Precio de la Acción Común,” o (ii) una fórmula basada en el número de acciones. Las acciones no convertidas podrán ser redimidas. La oferta será listada en la NYSE como “NLY.J” dentro de los 30 días posteriores a la emisión, sujeto a aprobación.

Uso de los ingresos: Los ingresos netos financiarán las inversiones objetivo de Annaly—MBS de Agencia, posiciones TBA, derechos de servicio hipotecario y activos de crédito residencial—y para propósitos corporativos generales. No se ha asignado calificación. La transferencia y propiedad están limitadas al 9,8% para proteger el estatus REIT, y los derechos de voto están limitados a las disposiciones protectoras habituales.

Annaly Capital Management (NYSE: NLY)는 예비 424B5 증권 설명서 보충서를 제출하여 시리즈 J 고정금리 누적 상환 우선주를 미정수량으로 발행할 예정이며, 청산 우선권은 $25입니다. 배당 쿠폰(%)은 아직 확정되지 않았습니다. 현금 배당금은 발행일로부터 누적되며, 분기별로 2025년 12월 31일부터(첫 기간은 장기) 지급되며, 누적 배당입니다.

상환 및 전환: 해당 주식은 2030년 9월 30일까지 상환 불가하며, 단 REIT 지위 유지 또는 지배권 변경(CoC) 시 예외입니다. 이후 Annaly는 미지급 배당금을 포함해 $25에 상환할 수 있습니다. CoC 발생 시 보유자는 (i) 청산 우선권과 누적 배당금을 ‘보통주 가격’으로 나눈 값과 (ii) 주식 수 기준 공식 중 더 낮은 금액으로 보통주로 전환할 수 있습니다. 전환하지 않은 주식은 상환될 수 있습니다. 발행 후 30일 이내에 NYSE에 “NLY.J”로 상장될 예정이며, 승인 조건이 있습니다.

자금 사용: 순수익은 Annaly의 목표 투자처인 에이전시 MBS, TBA 포지션, 모기지 서비스 권리 및 주택담보대출 신용 자산과 일반 기업 목적에 사용됩니다. 신용 등급은 부여되지 않았습니다. 양도 및 소유는 REIT 지위 보호를 위해 9.8%로 제한되며, 의결권은 통상적인 보호 조항으로 제한됩니다.

Annaly Capital Management (NYSE : NLY) a déposé un supplément préliminaire au prospectus 424B5 pour émettre un nombre indéterminé d’actions privilégiées cumulatives rachetables à taux fixe Série J avec une préférence de liquidation de 25 $. Le coupon de dividende, exprimé en « % », n’a pas encore été fixé. Les dividendes en espèces s’accumuleront à partir de la date d’émission et seront versés trimestriellement, à compter du 31 décembre 2025 (première période longue), et seront cumulatifs.

Rachat et conversion : Les actions sont non rachetables avant le 30 septembre 2030, sauf pour préserver le statut REIT ou en cas de changement de contrôle (CoC). Par la suite, Annaly pourra racheter à 25 $ plus les dividendes impayés. En cas de CoC, les détenteurs peuvent choisir de convertir en actions ordinaires au moindre de (i) la préférence de liquidation plus les dividendes accumulés divisés par le « prix de l’action ordinaire », ou (ii) une formule basée sur le nombre d’actions. Les actions non converties peuvent être rachetées. L’offre sera cotée au NYSE sous le symbole « NLY.J » dans les 30 jours suivant l’émission, sous réserve d’approbation.

Utilisation des fonds : Le produit net financera les investissements ciblés d’Annaly — MBS d’agence, positions TBA, droits de service hypothécaire et actifs de crédit résidentiel — ainsi que les besoins généraux de l’entreprise. Aucune notation n’a été attribuée. Le transfert/la propriété sont plafonnés à 9,8 % pour protéger le statut REIT, et les droits de vote sont limités aux dispositions protectrices habituelles.

Annaly Capital Management (NYSE: NLY) hat einen vorläufigen 424B5-Prospektergänzung eingereicht, um eine unbestimmte Anzahl von Series J festverzinslichen kumulativen rückzahlbaren Vorzugsaktien mit einer Liquidationspräferenz von 25 $ auszugeben. Der Dividendenkupon in Prozent wurde noch nicht festgelegt. Bardividenden werden ab dem Ausgabedatum vierteljährlich gezahlt, beginnend am 31. Dezember 2025 (langer erster Zeitraum), und sind kumulativ.

Rückzahlung & Umwandlung: Die Aktien sind bis zum 30. September 2030 nicht rückzahlbar, außer zur Wahrung des REIT-Status oder nach einer Kontrolländerung (CoC). Danach kann Annaly zum Preis von 25 $ zuzüglich nicht gezahlter Dividenden zurückzahlen. Bei einer CoC können Inhaber wählen, in Stammaktien zu konvertieren, und zwar zum geringeren Wert von (i) Liquidationspräferenz plus aufgelaufene Dividenden geteilt durch den „Stammaktienpreis“ oder (ii) einer aktienbasierten Formel. Nicht konvertierte Aktien können zurückgezahlt werden. Das Angebot wird innerhalb von 30 Tagen nach Ausgabe an der NYSE unter dem Symbol „NLY.J“ gelistet, vorbehaltlich der Genehmigung.

Verwendung der Erlöse: Die Nettoerlöse werden Annalys gezielte Investitionen finanzieren – Agency-MBS, TBA-Positionen, Hypotheken-Servicing-Rechte und Wohnkreditvermögen – sowie allgemeine Unternehmenszwecke. Es wurde keine Bewertung vergeben. Übertragungen/Eigentum sind auf 9,8 % begrenzt, um den REIT-Status zu schützen, und Stimmrechte sind auf übliche Schutzbestimmungen beschränkt.

Positive
  • Strengthens permanent capital: preferred proceeds enhance equity cushion without common dilution.
  • Fixed-rate funding through 2030 limits repricing risk in a rising-rate environment.
  • Flexibility: optional redemption and CoC conversion provide capital-management levers.
Negative
  • Undisclosed coupon creates pricing uncertainty for both issuer and investors.
  • Incremental leverage: preferred dividends rank senior to common and are not tax-deductible.
  • Share-cap on CoC conversion may limit upside for holders in a takeover scenario.

Insights

TL;DR – Capital raise diversifies funding; small EPS impact, neutral to common.

The preferred issue extends Annaly’s liability duration: coupons are fixed through 2030, then subject to redemption. This adds permanent, non-maturing capital that does not dilute common stock—dividends are contractually senior but non-tax-deductible. Leverage rises modestly yet proceeds target core mortgage assets, which should be accretive to net interest income. Absence of coupon guidance limits pricing clarity; final terms will determine cost efficiency. Overall, the filing is capital-structure neutral and maintains flexibility via CoC conversion and REIT-preservation redemption.

TL;DR – New series slots pari-passu with NLY.F/G/I; investor yield pending.

Series J ranks equally with existing F, G and I preferreds, ahead of common stock, and below debt. Non-call to 2030 plus cumulative dividends should appeal to income investors, but blank coupon creates execution risk. Share-cap limits upside on CoC conversion, while 9.8% ownership cap may restrict block investors. For Annaly, locking in fixed-rate funding hedges against rising short rates. Market impact likely muted until pricing details emerge.

Annaly Capital Management (NYSE: NLY) ha depositato un prospetto supplementare preliminare 424B5 per emettere un numero non specificato di azioni privilegiate cumulative rimborsabili a tasso fisso Serie J con una preferenza di liquidazione di $25. Il tasso del dividendo, espresso in “%,” non è ancora stato fissato. I dividendi in contanti matureranno dalla data di emissione e saranno pagati trimestralmente, a partire dal 31 dicembre 2025 (primo periodo lungo), e saranno cumulativi.

Rimborso e conversione: Le azioni sono non rimborsabili fino al 30 settembre 2030, salvo per preservare lo status REIT o in seguito a un cambio di controllo (CoC). Successivamente, Annaly potrà rimborsare a $25 più i dividendi non pagati. In caso di CoC, i detentori possono scegliere di convertire in azioni ordinarie al minore tra (i) la preferenza di liquidazione più i dividendi maturati diviso il “Prezzo delle Azioni Ordinarie,” o (ii) una formula basata sul numero di azioni. Le azioni non convertite potranno essere rimborsate. L’offerta sarà quotata alla NYSE come “NLY.J” entro 30 giorni dall’emissione, soggetta ad approvazione.

Utilizzo dei proventi: I proventi netti finanzieranno gli investimenti mirati di Annaly—MBS Agency, posizioni TBA, diritti di servicing ipotecario e attività di credito residenziale—e scopi aziendali generali. Non è stata assegnata alcuna valutazione. Il trasferimento e la proprietà sono limitati al 9,8% per proteggere lo status REIT, e i diritti di voto sono limitati alle consuete clausole protettive.

Annaly Capital Management (NYSE: NLY) ha presentado un suplemento preliminar 424B5 al prospecto para emitir un número no especificado de acciones preferentes acumulativas redimibles a tasa fija Serie J con una preferencia de liquidación de $25. El cupón del dividendo, expresado en “%,” aún no ha sido fijado. Los dividendos en efectivo se acumularán desde la fecha de emisión y se pagarán trimestralmente, comenzando el 31 de diciembre de 2025 (primer período largo), y serán acumulativos.

Redención y conversión: Las acciones son no redimibles hasta el 30 de septiembre de 2030, excepto para preservar el estatus REIT o tras un Cambio de Control (CoC). Posteriormente, Annaly podrá redimir a $25 más los dividendos no pagados. En caso de un CoC, los tenedores pueden optar por convertir en acciones ordinarias al menor entre (i) la preferencia de liquidación más los dividendos acumulados divididos por el “Precio de la Acción Común,” o (ii) una fórmula basada en el número de acciones. Las acciones no convertidas podrán ser redimidas. La oferta será listada en la NYSE como “NLY.J” dentro de los 30 días posteriores a la emisión, sujeto a aprobación.

Uso de los ingresos: Los ingresos netos financiarán las inversiones objetivo de Annaly—MBS de Agencia, posiciones TBA, derechos de servicio hipotecario y activos de crédito residencial—y para propósitos corporativos generales. No se ha asignado calificación. La transferencia y propiedad están limitadas al 9,8% para proteger el estatus REIT, y los derechos de voto están limitados a las disposiciones protectoras habituales.

Annaly Capital Management (NYSE: NLY)는 예비 424B5 증권 설명서 보충서를 제출하여 시리즈 J 고정금리 누적 상환 우선주를 미정수량으로 발행할 예정이며, 청산 우선권은 $25입니다. 배당 쿠폰(%)은 아직 확정되지 않았습니다. 현금 배당금은 발행일로부터 누적되며, 분기별로 2025년 12월 31일부터(첫 기간은 장기) 지급되며, 누적 배당입니다.

상환 및 전환: 해당 주식은 2030년 9월 30일까지 상환 불가하며, 단 REIT 지위 유지 또는 지배권 변경(CoC) 시 예외입니다. 이후 Annaly는 미지급 배당금을 포함해 $25에 상환할 수 있습니다. CoC 발생 시 보유자는 (i) 청산 우선권과 누적 배당금을 ‘보통주 가격’으로 나눈 값과 (ii) 주식 수 기준 공식 중 더 낮은 금액으로 보통주로 전환할 수 있습니다. 전환하지 않은 주식은 상환될 수 있습니다. 발행 후 30일 이내에 NYSE에 “NLY.J”로 상장될 예정이며, 승인 조건이 있습니다.

자금 사용: 순수익은 Annaly의 목표 투자처인 에이전시 MBS, TBA 포지션, 모기지 서비스 권리 및 주택담보대출 신용 자산과 일반 기업 목적에 사용됩니다. 신용 등급은 부여되지 않았습니다. 양도 및 소유는 REIT 지위 보호를 위해 9.8%로 제한되며, 의결권은 통상적인 보호 조항으로 제한됩니다.

Annaly Capital Management (NYSE : NLY) a déposé un supplément préliminaire au prospectus 424B5 pour émettre un nombre indéterminé d’actions privilégiées cumulatives rachetables à taux fixe Série J avec une préférence de liquidation de 25 $. Le coupon de dividende, exprimé en « % », n’a pas encore été fixé. Les dividendes en espèces s’accumuleront à partir de la date d’émission et seront versés trimestriellement, à compter du 31 décembre 2025 (première période longue), et seront cumulatifs.

Rachat et conversion : Les actions sont non rachetables avant le 30 septembre 2030, sauf pour préserver le statut REIT ou en cas de changement de contrôle (CoC). Par la suite, Annaly pourra racheter à 25 $ plus les dividendes impayés. En cas de CoC, les détenteurs peuvent choisir de convertir en actions ordinaires au moindre de (i) la préférence de liquidation plus les dividendes accumulés divisés par le « prix de l’action ordinaire », ou (ii) une formule basée sur le nombre d’actions. Les actions non converties peuvent être rachetées. L’offre sera cotée au NYSE sous le symbole « NLY.J » dans les 30 jours suivant l’émission, sous réserve d’approbation.

Utilisation des fonds : Le produit net financera les investissements ciblés d’Annaly — MBS d’agence, positions TBA, droits de service hypothécaire et actifs de crédit résidentiel — ainsi que les besoins généraux de l’entreprise. Aucune notation n’a été attribuée. Le transfert/la propriété sont plafonnés à 9,8 % pour protéger le statut REIT, et les droits de vote sont limités aux dispositions protectrices habituelles.

Annaly Capital Management (NYSE: NLY) hat einen vorläufigen 424B5-Prospektergänzung eingereicht, um eine unbestimmte Anzahl von Series J festverzinslichen kumulativen rückzahlbaren Vorzugsaktien mit einer Liquidationspräferenz von 25 $ auszugeben. Der Dividendenkupon in Prozent wurde noch nicht festgelegt. Bardividenden werden ab dem Ausgabedatum vierteljährlich gezahlt, beginnend am 31. Dezember 2025 (langer erster Zeitraum), und sind kumulativ.

Rückzahlung & Umwandlung: Die Aktien sind bis zum 30. September 2030 nicht rückzahlbar, außer zur Wahrung des REIT-Status oder nach einer Kontrolländerung (CoC). Danach kann Annaly zum Preis von 25 $ zuzüglich nicht gezahlter Dividenden zurückzahlen. Bei einer CoC können Inhaber wählen, in Stammaktien zu konvertieren, und zwar zum geringeren Wert von (i) Liquidationspräferenz plus aufgelaufene Dividenden geteilt durch den „Stammaktienpreis“ oder (ii) einer aktienbasierten Formel. Nicht konvertierte Aktien können zurückgezahlt werden. Das Angebot wird innerhalb von 30 Tagen nach Ausgabe an der NYSE unter dem Symbol „NLY.J“ gelistet, vorbehaltlich der Genehmigung.

Verwendung der Erlöse: Die Nettoerlöse werden Annalys gezielte Investitionen finanzieren – Agency-MBS, TBA-Positionen, Hypotheken-Servicing-Rechte und Wohnkreditvermögen – sowie allgemeine Unternehmenszwecke. Es wurde keine Bewertung vergeben. Übertragungen/Eigentum sind auf 9,8 % begrenzt, um den REIT-Status zu schützen, und Stimmrechte sind auf übliche Schutzbestimmungen beschränkt.

false 0001712762 0001712762 2025-07-29 2025-07-29 0001712762 BIAF:CommonStockParValue0.007PerShareMember 2025-07-29 2025-07-29 0001712762 BIAF:WarrantsToPurchaseCommonStockMember 2025-07-29 2025-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 29, 2025

 

bioAffinity Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41463   46-5211056

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

3300 Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(Address of principal executive offices, including zip code)

 

(210) 698-5334

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Title of each class   Trading Symbols   Name of each exchange on which registered

Common Stock, par value $0.007 per share

 

 

 

BIAF

 

 

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

         
Warrants to purchase Common Stock   BIAFW  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

On July 29, 2025, bioAffinity Technologies, Inc., a Delaware corporation, (the “Company”) issued a press release announcing the release of a new case study in which CyPath® Lung detected Stage 1A pulmonary mucinous adenocarcinoma in a high-risk individual whose previous tests and follow-up scans had suggested a low probability of cancer.

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number
  Description
99.1   Press Release issued by bioAffinity Technologies, Inc., dated July 29, 2025
104   Cover Page Interactive Data File (embedded within the XBRL document)

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 31, 2025 BIOAFFINITY TECHNOLOGIES, INC.
   
  By: /s/ Maria Zannes
  Name: Maria Zannes
  Title: President and Chief Executive Officer

 

-3-

 

FAQ

What is Annaly Capital (NLY) offering in this prospectus?

An unspecified number of Series J Fixed-Rate Cumulative Redeemable Preferred shares with a $25 liquidation preference.

When can Annaly redeem the Series J preferred stock?

The shares are non-redeemable until 30 Sep 2030, except to preserve REIT status or after a Change of Control.

Will the Series J preferred pay a fixed dividend?

Yes; the rate is fixed for life of the security, but the exact percentage is not yet disclosed in the preliminary filing.

How often are dividends paid on NLY.J?

Dividends accrue daily and are paid quarterly in arrears at the end of March, June, September and December.

What are the intended uses of the offering proceeds?

Annaly plans to acquire Agency MBS, TBA positions, MSRs and residential credit assets and for general corporate purposes.

Will the Series J preferred be listed for trading?

Annaly intends to list the shares on the NYSE under the symbol NLY.J within 30 days of issuance, subject to approval.
bioAffinity Tech

NASDAQ:BIAFW

BIAFW Rankings

BIAFW Latest News

BIAFW Latest SEC Filings

BIAFW Stock Data

1.60M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
SAN ANTONIO